GT Biopharma Inc/$GTBP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GT Biopharma Inc
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
Ticker
$GTBP
Sector
Primary listing
Employees
1
Headquarters
Website
GT Biopharma Inc Metrics
BasicAdvanced
$15M
-
-$6.25
1.19
-
Price and volume
Market cap
$15M
Beta
1.19
52-week high
$3.85
52-week low
$0.39
Average daily volume
805K
Financial strength
Current ratio
3.495
Quick ratio
2.937
Interest coverage (TTM)
-97.81%
Profitability
Management effectiveness
Return on assets (TTM)
-125.85%
Return on equity (TTM)
-1,377.41%
Valuation
Price to book
2.07
Price to tangible book (TTM)
2.07
Price to free cash flow (TTM)
-0.197
Free cash flow yield (TTM)
-508.85%
Free cash flow per share (TTM)
-2.384
Growth
Earnings per share change (TTM)
-9.93%
3-year earnings per share growth (CAGR)
-31.76%
GT Biopharma Inc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GT Biopharma Inc stock?
GT Biopharma Inc (GTBP) has a market cap of $15M as of March 24, 2026.
What is the P/E ratio for GT Biopharma Inc stock?
The price to earnings (P/E) ratio for GT Biopharma Inc (GTBP) stock is 0 as of March 24, 2026.
Does GT Biopharma Inc stock pay dividends?
No, GT Biopharma Inc (GTBP) stock does not pay dividends to its shareholders as of March 24, 2026.
When is the next GT Biopharma Inc dividend payment date?
GT Biopharma Inc (GTBP) stock does not pay dividends to its shareholders.
What is the beta indicator for GT Biopharma Inc?
GT Biopharma Inc (GTBP) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.